Clinical Trials Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jul 21, 2015; 21(27): 8398-8407
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8398
Figure 2
Figure 2 SLITRK3 mRNA expression in 35 gastrointestinal stromal tumor tissues with different risk grades (aP < 0. 05, group 1 vs group 2; bP < 0.01, group 1 vs group 3). The SLITRK3 mRNA levels in GIST tumor tissues of the high risk group (group 3) and intermediate risk group (group 2) were significantly higher than those of the low-risk group (group 1) (P = 0.003 and P = 0.044).